ADAMIS PHARMACEUTICALS CORP's ticker is ADMP and the CUSIP is 00547W208. A total of 51 filers reported holding ADAMIS PHARMACEUTICALS CORP in Q2 2019. The put-call ratio across all filers is 3.32 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $1 | – | 8,930 | +263.0% | 0.00% | – |
| Q4 2022 | $0 | -100.0% | 2,460 | -54.3% | 0.00% | – |
| Q3 2022 | $1,000 | -90.9% | 5,388 | -54.9% | 0.00% | – |
| Q1 2021 | $11,000 | +1000.0% | 11,938 | +1372.0% | 0.00% | – |
| Q2 2019 | $1,000 | -99.0% | 811 | -97.3% | 0.00% | – |
| Q3 2018 | $104,000 | -11.1% | 29,836 | -11.4% | 0.00% | -100.0% |
| Q1 2018 | $117,000 | +3800.0% | 33,668 | +4744.3% | 0.01% | – |
| Q4 2017 | $3,000 | -97.7% | 695 | -97.3% | 0.00% | -100.0% |
| Q3 2017 | $133,000 | +183.0% | 25,466 | +179.2% | 0.01% | +150.0% |
| Q2 2017 | $47,000 | +4.4% | 9,122 | -36.3% | 0.00% | -33.3% |
| Q4 2016 | $45,000 | -53.1% | 14,313 | -49.4% | 0.00% | -57.1% |
| Q3 2016 | $96,000 | +1271.4% | 28,269 | +2314.1% | 0.01% | +600.0% |
| Q1 2016 | $7,000 | -61.1% | 1,171 | -75.2% | 0.00% | -50.0% |
| Q1 2015 | $18,000 | – | 4,713 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| A.R.T. Advisors, LLC | 20,419 | $16,000 | 0.09% |
| Maven Securities LTD | 1,000,000 | $795,000 | 0.07% |
| Verdence Capital Advisors LLC | 88,382 | $69,000 | 0.02% |
| Hayden Royal, LLC | 26,000 | $20,000 | 0.01% |
| GSA CAPITAL PARTNERS LLP | 55,752 | $44,000 | 0.01% |
| Qube Research & Technologies Ltd | 519,063 | $407,000 | 0.01% |
| Virtu Financial LLC | 39,683 | $31,000 | 0.01% |
| Global Strategic Investment Solutions, LLC | 23,000 | $18,000 | 0.01% |
| Jacobi Capital Management LLC | 25,000 | $20,000 | 0.00% |
| RVW Wealth, LLC | 19,000 | $15,000 | 0.00% |